Neuroendocrine tumors laboratory findings: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Neuroendocrine tumors}} | {{Neuroendocrine tumors}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
{{CMG}} | {{CMG}} | ||
| Line 68: | Line 71: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs content]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 20:59, 30 August 2012
|
Neuroendocrine tumors Microchapters |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Laboratory Findings
Cells that receive hormonal messages do so through receptors on the surface of the cells. For reasons that are not understood, many neuroendocrine tumor cells possess especially strong receptors; for example, PETs often have strong receptors for somatostatin, a very common hormone in the body. We say that such tumor cells overexpress the somatostatin receptors (SSTRs) and are thus avid for the hormone; their uptake of the hormone is strong. This avidity for somatostatin is a key for diagnosis – and it makes the tumors vulnerable to certain targeted therapies.
The list of potential markers for GEP-NETs is long. Aside from the hormones of secretory tumors, the most important markers are
- Chromogranin A (CgA)
- Urine 5-hydroxy indole acetic acid (5-HIAA) (grade C)
- Neuron-specific enolase (NSE, gamma-gamma dimer)
- Synaptophysin (P38)
and other markers include
- Synaptobrevin (VAMP-1)
- Synapsin (1A, 1B, 2A, 2B)
- SV2
- Protein P65
- Protein S-100
- Protein gene product (PGP) 9.5
- Intermediate filaments (cytokeratins, vimentin, neurofilaments)
- Protein 7B2
- Chromogranin B (secretogranin I)
- Chromogranin C (secretogranin II)
- Pancreastatin
- Vasostatin
- Cytochrome b561
- Leu-7 (HNK-1)
- Calcitonin
- Human chorionic gonadotropin-alpha (HCG-α)
- Human chorionic gonadotropin-beta (HCG-β)
- Thyroid function tests (TFTs)
- Parathyroid hormone (PTH)
- Calcium
- Prolactin
- {Alpha}-fetoprotein
- Carcinoembryonic antigen (CEA)
- ß-human chorionic gonadotrophin (ß-HCG) (grade D)
- CGRP
- GRP
- PYY
- hCGα
- N Peptide K
- Neurokinin A
- Serotonin
- Neurotensin
- Motilin
- Substance P
- Histamine
- Catecholamines
- Dopa
- Various rarer peptide hormones
- Synaptotagmin
- HISL-19
and newer (as of 2005) markers include
- N-terminally truncated variant of heat shock protein 70 (Hsp70)
- CDX-2, a homeobox gene product
- Neuroendocrine secretory protein-55
Aside from their use in diagnosis, some markers can track the progress of therapy while the patient avoids the detrimental side-effects of CT-scan contrast.